Back

Spontaneous emergence of non-convertible cell states with CD24-High phenotype results in phenotypic heterogeneity that associates with poor prognosis in oral cancer

Vipparthi, K.; Hari, K.; Chakraborty, P.; Ghosh, S.; Patel, A.; Ghosh, A.; Biswas, N. K.; Sharan, R.; Arun, P.; Jolly, M. K.; Singh, S.

2021-08-24 cancer biology
10.1101/2021.08.24.457509 bioRxiv
Show abstract

PurposeCellular dynamics between phenotypically heterogeneous subpopulations of cancer cells within individual tumor is shown to be responsible for drug tolerance and overall poor prognosis; however, evidences were largely missing in oral cancer. Therefore, this study was undertaken to describe the dynamic phenotypic states among oral cancer cells, its influence on transcriptomic heterogeneity as well as its clinical significance. Experimental DesignWe multiplexed phenotypic markers of putative oral-stem-like cancer cells (SLCCs) and characterized diversity among CD44-positive oral cancer cell subpopulations with respect to distinct expression of CD24 and aldehyde dehydrogenase (ALDH)-activity in multiple cell lines. Population trajectories were characterized by Markov model and cell states were defined based on the population specific RNA sequencing (RNAseq). ssGSEA based gene expression signatures were explore for prognostic significance. ResultsOral cancer cells followed two distinct patterns of spontaneous repopulation dynamics with stochastic inter-conversions on ALDH-axis, however a strict non-interconvertible transition on CD24-axis. Interestingly, plastic ALDH-axis was harnessed to enrich ALDHHigh subpopulations in response to Cisplatin treatment, to adapt a drug tolerant state. Phenotype-specific RNAseq results suggested the organization of subpopulations into hierarchical structure with possible maintenance of intermediate states of stemness within the differentiating oral cancer cells. Further, survival analysis with each subpopulation-specific gene signature strongly suggested that the cell-state dynamics may act as possible mechanism to drive ITH, resulting in poor prognosis in patient. ConclusionsOur results emphasized the prognostic power of the population dynamics in oral cancer. Importantly, we have described the phenotypic-composition of heterogeneous subpopulations critical for global tumor behaviour in oral cancer; which is a prerequisite knowledge important for precision treatment, however largely lacking for most solid tumors. Graphical AbstractWe have characterized diversity among CD44-positive oral cancer cells lines with respect to distinct expression of CD24 and ALDH-activity. Subpopulations showed stochastic inter-conversions on ALDH-axis but a strict non-interconvertible transition of CD24Low to CD24High phenotype, even in response to chemotherapy-induced stress. RNAseq study suggested the organization of subpopulations into hierarchical structure with possible maintenance of intermediate alternate states of stemness within the differentiating oral cancer cells. The described population dynamics demonstrtaed influence tumor behaviour possibly by increasing intratumoral heterogeneity in aggressive oral tumors. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=112 SRC="FIGDIR/small/457509v3_ufig1.gif" ALT="Figure 1"> View larger version (20K): org.highwire.dtl.DTLVardef@1dc6a7org.highwire.dtl.DTLVardef@dd0948org.highwire.dtl.DTLVardef@18c9603org.highwire.dtl.DTLVardef@cca8fb_HPS_FORMAT_FIGEXP M_FIG C_FIG Translational relevanceIntratumoral heterogeneity (ITH) has been the clinically important factor, impacting aggressive cancer behaviour, drug tolerance and overall poor prognosis. Recent high-throughput studies have provided better cellular and molecular resolution of ITH; however, the prerequisite knowledge which defines the composition of subpopulations critical for global tumor behaviour is majorly lacking for most of the solid tumors. By combining phenotypic markers, we have defined four subpopulations of oral cancer cells. These subpopulations showed stochastic inter-conversions as well as a strict non-interconvertible transition among them to acheive heterogeneity. Importantly, transcriptional states of each subpopulations indicated a clinically relevant signatures for patient prognosis. Also, we observed interconversions of these subpopulations in response to Cisplatin to accumulate drug-tolerant cell state, as rapid and reversible strategy to respond to chemotherapy induced stress. Thus, the characteristics of described phenotypic subgroups may be translated to the clinic for estimating the extent of intratumoral heterogeneity in oral cancer patients.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Frontiers in Oncology
95 papers in training set
Top 0.1%
22.3%
2
Cancers
200 papers in training set
Top 0.2%
14.2%
3
Molecular Oncology
50 papers in training set
Top 0.1%
4.8%
4
Scientific Reports
3102 papers in training set
Top 28%
4.3%
5
PLOS ONE
4510 papers in training set
Top 36%
3.9%
6
Oncotarget
15 papers in training set
Top 0.1%
3.5%
50% of probability mass above
7
BMC Cancer
52 papers in training set
Top 0.7%
3.0%
8
British Journal of Cancer
42 papers in training set
Top 0.6%
2.4%
9
Cells
232 papers in training set
Top 2%
2.1%
10
International Journal of Cancer
42 papers in training set
Top 0.6%
1.8%
11
Cancer Medicine
24 papers in training set
Top 0.8%
1.7%
12
International Journal of Molecular Sciences
453 papers in training set
Top 9%
1.5%
13
eBioMedicine
130 papers in training set
Top 2%
1.5%
14
Translational Oncology
18 papers in training set
Top 0.2%
1.3%
15
Journal of Translational Medicine
46 papers in training set
Top 1%
1.3%
16
Heliyon
146 papers in training set
Top 3%
1.3%
17
PeerJ
261 papers in training set
Top 10%
1.2%
18
Journal of Experimental & Clinical Cancer Research
25 papers in training set
Top 0.2%
0.9%
19
Cancer Research Communications
46 papers in training set
Top 0.8%
0.9%
20
Computational Biology and Chemistry
23 papers in training set
Top 0.4%
0.9%
21
iScience
1063 papers in training set
Top 27%
0.9%
22
Oncogene
76 papers in training set
Top 2%
0.9%
23
Cancer Letters
32 papers in training set
Top 0.6%
0.9%
24
Frontiers in Pharmacology
100 papers in training set
Top 4%
0.9%
25
Biomedicines
66 papers in training set
Top 3%
0.8%
26
Genes
126 papers in training set
Top 3%
0.8%
27
Epigenetics
43 papers in training set
Top 1%
0.7%
28
The Journal of Pathology
22 papers in training set
Top 0.5%
0.7%
29
JCI Insight
241 papers in training set
Top 8%
0.7%
30
Biomolecules
95 papers in training set
Top 3%
0.7%